Aphasia, Development, Human, Neuropathology
Conditions
Keywords
aphasia, memory, learning, language, adults, seniors
Brief summary
The goal of this observational study is to investigate cognitive functioning profiles in adults with neurologically recognized aphasic syndromes and general population. The study group consist of minimal 600 adults (over 18 y.o.) who will be examined by qualified diagnosticians. Participants will be evaluated with tasks related to the studied variables: memory, learning and language. Furthermore informations regarding past and present health condition will be collected from participants. The main questions it aims to answer are: 1. What is the profile of memory and learning among polish adults? 2. Do gender and age moderates patterns of memory and learning functioning among polish adults? 3. What is a specific pattern of language functioning in adults with neurologically recognized aphasic syndromes? 4. Do gender moderates specific patterns of language functioning in adults with neurologically recognized aphasic syndromes? Researchers will compare the following groups of adults: 1. general population/control group 2. with neurologically recognized aphasic syndromes 3. seniors (over 60 y.o.)
Interventions
DIAGNOSTIC_TESTPsychological assessment
Psychological assessment of memory, learning and language
Sponsors
Bartosz M. Radtke
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
for general population/control group: * age from 18 to 60 y.o. Inclusion criteria for neurologically recognized aphasic syndromes * age above 18 y.o. * neurologically recognized aphasic syndromes Inclusion criteria for seniors: * age above 60 y.o.
Exclusion criteria
for general population/control group: * age less then 18 y.o. * neurologically recognized aphasic syndromes
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Language | July 3, 2023 until June 30, 2026 | Boston Diagnostic Aphasia Examination-Third Edition. A spectrum of tools that helps to identify and distinguish among disorders of language function and neurologically recognized aphasic syndromes. The test have five functional subsections: 1) Conversational and Expository Speech, 2) Auditory Comprehension, 3) Oral Expression, 4) Reading and 5) Writing. The raw scores obtained in each tested subscale are converted into a percentile scale, ranging from 1 to 100, where a higher score means better functioning of the examined area, and a lower result means poorer functioning. |
| Memory and learning | July 3, 2023 until June 30, 2026 | Test of Memory and Learning (second edition). A standardized test measuring memory functioning and learning abilities. The test includes four basic factors (Verbal Memory, Nonverbal Memory, Complex Memory, and Delayed Recall) and five supplementary factors (Attention/Concentration, Sequential Memory, Free Recall, Associative Recall and Learning). The raw scores obtained in each tested subscale are converted into scores scaled based on age norms, ranging from 1 to 20, where a higher score means better functioning of the examined area, and a lower result means poorer functioning. |
| Socio-demographic data | July 3, 2023 until June 30, 2026 | Author's survey of socio-demographic data, including: gender, month and year of birth, region of residence |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| General mental state | July 3, 2023 until June 30, 2026 | Mini-Mental State Examination. A clinical scale used to examine disorders in a patient's cognitive functioning. The questionnaire consists a series of questions allowing the assessment of the following functions: 1) orientation in time and place, 2) attention/concentration, 3) short-term memory (recall), 4) language skills, 5) visual-spatial abilities, 6) ability to understand and follow the instructions. The maximum score that can be obtained on the test is 30 points. 27-30 is a correct result; 24-26 is a cognitive impairment without dementia; 19-23 mean mild dementia; 11-18 is a moderate degree dementia and 0-10 mean profound dementia. |
| Health related data | July 3, 2023 until June 30, 2026 | Author's survey of health related data, including: hearing, eyesight, hypertension, atherosclerosis, previous heart attack, diabetes, endocrine diseases, respiratory system diseases, musculoskeletal system diseases, nervous system diseases, kidney diseases, sleep disorders, hospitalizations, procedures under general anesthesia, cancer, medications. |
| Education data | July 3, 2023 until June 30, 2026 | Author's survey of education, including: years of education, level of education, occupation, level of education of the participant's parents. |
Countries
Poland
Contacts
CONTACTRafał Nowicki, M.A.
STUDY_DIRECTORUrszula Sajewicz-Radtke, Ph.D.
Laboratory of Psychological and Educational Tests
PRINCIPAL_INVESTIGATORBartosz M Radtke, Ph.D.
Laboratory of Psychological and Educational Tests
PRINCIPAL_INVESTIGATORAriadna Łada-Maśko, Ph.D.
Laboratory of Psychological and Educational Tests
Outcome results
None listed